1.
Hütter-Krönke M-L, Benner A, Döhner K, Krauter J, Weber D, Moessner M, Köhne C-H, Horst HA, Schmidt-Wolf IG, Rummel M, Götze K, Koller E, Petzer AL, Salwender H, Fiedler W, Kirchen H, Haase D, Kremers S, Theobald M, Matzdorff AC, Ganser A, Döhner H, Schlenk RF. Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy. Haematologica [Internet]. 2016Jun.30 [cited 2026Nov.17];101(7):839-45. Available from: https://haematologica.org/article/view/7770